Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy

BACKGROUND: Circulating tumor cells (CTCs) detected in peripheral blood (PB) of cancer patients can be identified as isolated CTCs and circulating tumor microemboli (CTM). This study aimed to evaluate the prognostic value of CTM detection and CTC phenotype in advanced colorectal cancer (CRC) patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dejun, Zhao, Lei, Zhou, Pengfei, Ma, Hong, Huang, Fang, Jin, Min, Dai, Xiaomeng, Zheng, Xiumei, Huang, Shaoyi, Zhang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217234/
https://www.ncbi.nlm.nih.gov/pubmed/28070168
http://dx.doi.org/10.1186/s12935-016-0373-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217234/
https://www.ncbi.nlm.nih.gov/pubmed/28070168
http://dx.doi.org/10.1186/s12935-016-0373-7

Ejemplares similares